Catabolism of Ap4A and Ap3A in whole blood
- 1 April 1988
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 173 (1) , 241-245
- https://doi.org/10.1111/j.1432-1033.1988.tb13990.x
Abstract
Adenosine(5')tetraphospho(5')adenosine (Ap4A) and adenosine(5')triphospho(5')adenosine (Ap3A) are stored in large amounts in human platelets. After activation of the platelets both dinucleotides are released into the extracellular milieu where they play a role in the modulation of platelet aggregation and also in the regulation of the vasotone. It has recently been shown that the dinucleotides are degraded by enzymes present in the plasma [Lüthje, J. & Ogilvie, A. (1987) Eur. J. Biochem. 169, 385-388]. The further metabolism as well as the role of blood cells has not been established. The dinucleotides were first degraded by plasma phosphodiesterases yielding ATP (ADP) plus AMP as products which were then metabolized to adenosine and inosine. The nucleosides did not accumulate but were very rapidly salvaged by erythrocytes yielding intracellular ATP as the main product. Although lysates of platelets, leucocytes and red blood cells contained large amounts of Ap3A-degrading and Ap4A-degrading activities, these activities were not detectable in suspensions of intact cells suggesting the lack of dinucleotide-hydrolyzing ectoenzymes. Compared to ATP, which is rapidly degraded by ectoenzymes present on blood cells, the half-life of Ap4A was two to three times longer. Since the dinucleotides are secreted together with ADP and ATP from the platelets, we tested the influence of ATP on the rate of degradation of Ap4A. ATP at concentrations present during platelet aggregation strongly inhibited the degradation of Ap4A in whole blood. It is suggested that in vivo the dinucleotides are protected from degradation immediately after their release. They may thus survive for rather long times and may act as signals even at sites far away from the platelet aggregate.Keywords
This publication has 22 references indexed in Scilit:
- Catabolism of Ap4A and Ap3A in human serum. Identification of isoenzymes and their partial characterizationEuropean Journal of Biochemistry, 1987
- Hydrolysis of diadenosine 5',5''-P',P''-triphosphate (Ap3A) by porcine aortic endothelial cells.Circulation Research, 1986
- Catabolism of Ap3A and Ap4A in human plasma. Purification and characterization of a glycoprotein complex with 5'-nucleotide phosphodiesterase activityEuropean Journal of Biochemistry, 1985
- Diadenosine triphosphate (Ap3A) mediates human platelet aggregation by liberation of ADPBiochemical and Biophysical Research Communications, 1984
- Dipyridamole inhibition of adenosine metabolism in human bloodEuropean Journal of Pharmacology, 1983
- The presence of diadenosine 5′,5‴-P 1 ,P 3 -triphosphate (Ap 3 A) in human plateletsBiochemical and Biophysical Research Communications, 1983
- Drug-sensitive ecto-ATPase in human leukocytesBiochemical Pharmacology, 1980
- Mg2+-ATPase as a membrane ecto-enzyme of human granulocytes. Inhibitors, activators and response to phagocytosisBiochimica et Biophysica Acta (BBA) - Biomembranes, 1978
- Inhibition of platelet aggregation and the platelet release reaction by α, ω diadenosine polyphosphatesFEBS Letters, 1975
- Characterization of “ecto-ATPase” of human blood plateletsArchives of Biochemistry and Biophysics, 1967